RELATED STUDY
Key Findings:
Type of Study:
Study Result: Inconclusive
Research Location(s):
Year of Pub:
Cannabinoids Studied:
Chemotype:
Terpenes Studied:
Receptors Studied:
Ligands Studied:
DOSING DETAILS 
Study Dosing Objective: Effective Dose
Established Protocol: Effective dose
Route of Administration:
Dosing Regimen: BCP (10 mg/kg, i.p. and 10 mg/kg through an oral gavage)
Treatment Duration: 5 consecutive days
Clinical Relevance: BCP acts via multiple neuroprotective mechanisms in our murine model and may be viewed as a potential treatment and/or preventative agent for PD.
Additional Notes: Pharmacokinetic Study Data
Citation:
